ACCESSION: MSBNK-SMB_Measured-HSA001P0142016
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 92
COMMENT: RAW_SPEC {'BLK01_5164': {'bp': 391727.0, 'sum': 1563619.0}, '17_posi_5191': {'bp': 286203.0, 'sum': 874071.0}, '4_posi_5295': {'bp': 289570.0, 'sum': 963811.0}, '13_posi_5295': {'bp': 317927.0, 'sum': 996653.0}, 'ProcedureBlank_5105': {'bp': 317980.0, 'sum': 1037027.0}, 'BLK02_5233': {'bp': 321601.0, 'sum': 1068042.0}, '19_posi_5170': {'bp': 326621.0, 'sum': 1062722.0}, '8_posi_5086': {'bp': 348996.0, 'sum': 1078435.0}, '18_posi_5169': {'bp': 361365.0, 'sum': 1102023.0}, '3_posi_5190': {'bp': 263640.0, 'sum': 885701.0}, '15_posi_5254': {'bp': 266830.0, 'sum': 841296.0}, '14_posi_5213': {'bp': 269217.0, 'sum': 839431.0}, '5_posi_5192': {'bp': 273780.0, 'sum': 832772.0}, '7_posi_5107': {'bp': 285620.0, 'sum': 870319.0}, '9_posi_5128': {'bp': 289441.0, 'sum': 932883.0}, 'ProcedureBlank_5232': {'bp': 296517.0, 'sum': 947497.0}, '1_posi_5294': {'bp': 304448.0, 'sum': 977444.0}, '3_posi_5063': {'bp': 306777.0, 'sum': 978936.0}, '10_posi_5150': {'bp': 307731.0, 'sum': 948390.0}, '11_posi_5127': {'bp': 308149.0, 'sum': 942483.0}, '12_posi_5129': {'bp': 309019.0, 'sum': 952010.0}, '13_posi_5105': {'bp': 322192.0, 'sum': 1018964.0}, '18_posi_5105': {'bp': 339137.0, 'sum': 1094438.0}, '9_posi_5254': {'bp': 221805.0, 'sum': 719287.0}, '1_posi_5231': {'bp': 246011.0, 'sum': 841841.0}, '9_posi_5191': {'bp': 254951.0, 'sum': 806517.0}, '19_posi_5295': {'bp': 259328.0, 'sum': 810620.0}, '5_posi_5318': {'bp': 266213.0, 'sum': 847353.0}, '6_posi_5169': {'bp': 275043.0, 'sum': 818409.0}, '9_posi_5319': {'bp': 276365.0, 'sum': 882583.0}, '10_posi_5213': {'bp': 280629.0, 'sum': 872428.0}, '12_posi_5192': {'bp': 281620.0, 'sum': 885662.0}, '13_posi_5168': {'bp': 283850.0, 'sum': 932620.0}, '7_posi_5170': {'bp': 285262.0, 'sum': 889715.0}, '15_posi_5126': {'bp': 285554.0, 'sum': 957301.0}, 'BLK02_5107': {'bp': 328451.0, 'sum': 1053776.0}, '19_posi_5106': {'bp': 332552.0, 'sum': 1061827.0}, '10_posi_5087': {'bp': 341150.0, 'sum': 1033259.0}, '9_posi_5065': {'bp': 341905.0, 'sum': 1051699.0}, 'BLK02_5297': {'bp': 342960.0, 'sum': 1137456.0}, '16_posi_5234': {'bp': 231545.0, 'sum': 741293.0}, '16_posi_5295': {'bp': 248243.0, 'sum': 786060.0}, '3_posi_5255': {'bp': 264313.0, 'sum': 846327.0}, '12_posi_5254': {'bp': 268336.0, 'sum': 850041.0}, '11_posi_5253': {'bp': 269804.0, 'sum': 827270.0}, '2_posi_5173': {'bp': 276545.0, 'sum': 875964.0}, '3_posi_5127': {'bp': 279794.0, 'sum': 889112.0}, '14_posi_5149': {'bp': 284142.0, 'sum': 860389.0}, '12_posi_5318': {'bp': 289274.0, 'sum': 950230.0}, 'ProcedureBlank_5168': {'bp': 290194.0, 'sum': 949503.0}, '6_posi_5108': {'bp': 305737.0, 'sum': 1009877.0}, '18_posi_5296': {'bp': 245157.0, 'sum': 773264.0}, '13_posi_5232': {'bp': 262498.0, 'sum': 839819.0}, '11_posi_5315': {'bp': 274998.0, 'sum': 902583.0}, '17_posi_5319': {'bp': 276108.0, 'sum': 833727.0}, '11_posi_5189': {'bp': 290336.0, 'sum': 937625.0}, '16_posi_5167': {'bp': 291162.0, 'sum': 896362.0}, '15_posi_5316': {'bp': 301485.0, 'sum': 977775.0}, '17_posi_5064': {'bp': 330617.0, 'sum': 1017931.0}, '10_posi_5277': {'bp': 297860.0, 'sum': 945839.0}, '16_posi_5104': {'bp': 298209.0, 'sum': 969058.0}, '17_posi_5127': {'bp': 293598.0, 'sum': 951350.0}, '15_posi_5063': {'bp': 305433.0, 'sum': 994641.0}, '3_posi_5317': {'bp': 269618.0, 'sum': 895120.0}, '12_posi_5064': {'bp': 303303.0, 'sum': 984308.0}, '2_posi_5298': {'bp': 266388.0, 'sum': 866808.0}, '5_posi_5254': {'bp': 264023.0, 'sum': 839665.0}, '4_posi_5172': {'bp': 262802.0, 'sum': 807363.0}, '6_posi_5234': {'bp': 249645.0, 'sum': 745075.0}, '8_posi_5150': {'bp': 351290.0, 'sum': 1076956.0}, '1_posi_5106': {'bp': 331869.0, 'sum': 1033927.0}, '14_posi_5086': {'bp': 316556.0, 'sum': 1007675.0}, '11_posi_5065': {'bp': 316223.0, 'sum': 1025417.0}, '6_posi_5297': {'bp': 302775.0, 'sum': 972096.0}, '2_posi_5235': {'bp': 296625.0, 'sum': 902068.0}, '5_posi_5064': {'bp': 291189.0, 'sum': 946634.0}, '19_posi_5232': {'bp': 283272.0, 'sum': 888720.0}, '8_posi_5214': {'bp': 275049.0, 'sum': 877514.0}, '4_posi_5108': {'bp': 274336.0, 'sum': 873485.0}, '7_posi_5232': {'bp': 266805.0, 'sum': 857204.0}, '17_posi_5253': {'bp': 255309.0, 'sum': 786876.0}, '4_posi_5233': {'bp': 242284.0, 'sum': 807969.0}, 'BLK02_5171': {'bp': 312431.0, 'sum': 1052645.0}, '7_posi_5297': {'bp': 284521.0, 'sum': 939548.0}, '15_posi_5190': {'bp': 278433.0, 'sum': 888257.0}, '8_posi_5277': {'bp': 268563.0, 'sum': 830424.0}, '14_posi_5274': {'bp': 259467.0, 'sum': 857825.0}, '2_posi_5107': {'bp': 317705.0, 'sum': 990355.0}, '1_posi_5168': {'bp': 308938.0, 'sum': 968052.0}, 'ProcedureBlank_5294': {'bp': 280617.0, 'sum': 956649.0}, '5_posi_5129': {'bp': 277736.0, 'sum': 866683.0}, '18_posi_5232': {'bp': 282066.0, 'sum': 863280.0}}
COMMENT: RETENTION_TIME_STDEV 0.159
COMMENT: PRECURSOR_M/Z_RAW 142.097244
COMMENT: PRECURSOR_M/Z_STDEV 0.000035
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.695; C6H11N3O; [M+H]+; delta(ppm) 0.694591
COMMENT: PROPOSED_MF MS-FINDER 3.284; C6H11N3O; [M+H]+; delta(ppm) 0.686662
COMMENT: PROPOSED_MF SIRIUS5_Sirius 36.422; C6H11N3O; [M+H]+; delta(ppm) 0.686662
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3O; [M+H]+; delta(ppm) 0.686662
COMMENT: PROPOSED_MF SIRIUS6_Sirius 53.594; C6H11N3O; [M+H]+; delta(ppm) 0.686662
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.641; C4H9N6; [M+H]+; delta(ppm) 10.135649
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.721; C8H13O2; [M+H]+; delta(ppm) -8.762145
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3O; [M+H]+; delta(ppm) 0.686662
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.634; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; N[C@H](CO)CC1=CN=CN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.903; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.812; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+H]+; (2S)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; OCEJLBIKKZYCBH-UHFFFAOYSA-N; [M+H]+; 1-(azetidin-3-yl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; WRNALNJFNAAVKM-UHFFFAOYSA-N; [M+H]+; 2,5,7-triazaspiro[3.5]nonan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; ASEMWMLOGSUFFL-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)-3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.163; RYFSOJLJCKEYBP-UHFFFAOYSA-N; [M+H]+; 3-(1-aminoethyl)-1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.157; OZGHNDLEHPCVJQ-UHFFFAOYSA-N; [M+H]+; 2-[4-(aminomethyl)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; ZQIOGDSNYJYBTN-UHFFFAOYSA-N; [M+H]+; 3-(3-aminopyrazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; QJCMYUTUCCCBMY-UHFFFAOYSA-N; [M+H]+; 1-(3-aminopyrazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; NMGPZPUIAUQPJA-UHFFFAOYSA-N; [M+H]+; [1-(2-aminoethyl)imidazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; LGPFTDILVKZMRC-UHFFFAOYSA-N; [M+H]+; 2-(3-amino-4-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; RTGLANPQFMENLF-UHFFFAOYSA-N; [M+H]+; 2,5,6,7,8,8a-hexahydro-1H-imidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; OZVXTNDTEWDMGH-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; QKHNQZUVFSQKFD-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; AJOFBNLXIBLIPM-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1-methylimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.137; VCPRZYKEIPMTGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(1-methylpyrazol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; ANQYOZSPKNDFPD-UHFFFAOYSA-N; [M+H]+; 2-(5-amino-3-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; HKUSMMLJSPSXCL-UHFFFAOYSA-N; [M+H]+; 5-(3-aminopropyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.132; IUBWCBLFKCGVGV-UHFFFAOYSA-N; [M+H]+; 2-(2-iminopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; GTEXXCCAHDQARI-UHFFFAOYSA-N; [M+H]+; 1-amino-3-pyrazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.117; VCSSOKBEBXXSDV-UHFFFAOYSA-N; [M+H]+; 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; IPLIJMUJLJBZDZ-UHFFFAOYSA-N; [M+H]+; 1-amino-3-imidazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; ITDOBWWRWYKLQJ-UHFFFAOYSA-N; [M+H]+; 2,3,4,5-tetrahydropyridin-6-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; YUTDFIMDLUJOJK-UHFFFAOYSA-N; [M+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; LHHBJUDYVRBYMB-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-2,5-dimethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; BMHYWTFRHPIOQM-UHFFFAOYSA-N; [M+H]+; 2-(2-oxopyrrolidin-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.991; LEWKFFUYRKWKLV-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-propan-2-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; VPOYXTRLFXNRJN-UHFFFAOYSA-N; [M+H]+; N-methyl-3-propan-2-yl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.978; JANUDBLANRHSLI-UHFFFAOYSA-N; [M+H]+; 5-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.964; YCXQDZIPLMEYGK-UHFFFAOYSA-N; [M+H]+; 2-[4-(methylamino)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; VWUSXTIUSAVEAQ-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; XIAOMTCYUPNRKB-UHFFFAOYSA-N; [M+H]+; (2-propan-2-yl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.919; ZPUGMHPXVOHOAZ-UHFFFAOYSA-N; [M+H]+; (4-propyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; SRIBOFCAJXTSEL-UHFFFAOYSA-N; [M+H]+; 1-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; IZYJJPFDVHGKAG-UHFFFAOYSA-N; [M+H]+; 2-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; WWGWIEDOVSRZPU-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; QOGFVKATFSDNGB-UHFFFAOYSA-N; [M+H]+; 2-(5-methyl-1,2,4-oxadiazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.885; PEPBWGGISBCQDW-UHFFFAOYSA-N; [M+H]+; (3-propan-2-yl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; AEBOLOPWWMZLBL-UHFFFAOYSA-N; [M+H]+; 2-(3-methyl-1,2,4-oxadiazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; KENWBTPXOITUBG-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; XGPRUICIGLRGSQ-UHFFFAOYSA-N; [M+H]+; (5-propan-2-yl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; KGTZRGLLNSCJNH-UHFFFAOYSA-N; [M+H]+; 5-(2-methylpropyl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; QYLRWTDPRQLHNV-UHFFFAOYSA-N; [M+H]+; 2-(3-methyldiazirin-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.821; VUQAASCCQZTWOG-UHFFFAOYSA-N; [M+H]+; 5-butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; YEKKCMQUYOKDQD-UHFFFAOYSA-N; [M+H]+; 3-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; ILUUSWWGUOPVLO-UHFFFAOYSA-N; [M+H]+; 3-tert-butyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; WONCYNYJYMAVNA-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; XWBPAFFFOLTPTR-UHFFFAOYSA-N; [M+H]+; 3-(methoxymethyl)-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.744; KJASFPYFMYPMHS-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-2-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.742; LURMHCWOXHNATM-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; YGJWTXRSKNXUAY-UHFFFAOYSA-N; [M+H]+; 5-methoxy-1,3-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.735; UXZYNPKVFMWVMT-UHFFFAOYSA-N; [M+H]+; 1-ethyl-3-methoxypyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.731; BIJFXVFSSOVINP-UHFFFAOYSA-N; [M+H]+; 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.728; OANNGOSSNLIIIV-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1,5-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.727; WBHVOQXHRCGQTP-UHFFFAOYSA-N; [M+H]+; 1-(3-ethyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.715; MGDACALOFCAYGF-UHFFFAOYSA-N; [M+H]+; (3-methoxy-1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.713; CIZWSGSWDKEWQD-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.704; REYGCAPKUGCICS-UHFFFAOYSA-N; [M+H]+; N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.700; VAYGOKAONCMZCM-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.682; KJTMKVRSTYLHQN-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.676; VQNRBFXKOWOEAC-UHFFFAOYSA-N; [M+H]+; 3-ethoxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.103; ITDOBWWRWYKLQJ; [M+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.700; YDDAGKSURVEMCI; [M+H]+; Acetamide, 2-diazo-N,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.582; YUTDFIMDLUJOJK; [M+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.337; KENWBTPXOITUBG; [M+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.338; UEUMMYRZUZKMRI; [M+H]+; Ambap52883-26-8
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.155; ZQISRDCJNBUVMM; [M+H]+; histidol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.188; WONCYNYJYMAVNA; [M+H]+; 2-Amino-5-tert-butyl-1,3,4-oxadiazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.344; QIXFXNMDRJRTIJ; [M+H]+; 1-Hem-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.426; DUCOZVHXTHIRIB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.570; LURMHCWOXHNATM; [M+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.117; CIZWSGSWDKEWQD; [M+H]+; 1-(2-methoxyethyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.285; IPLIJMUJLJBZDZ; [M+H]+; 3-amino-1-imidazolylpropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.594; ITDOBWWRWYKLQJ; [M+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -174.963; REYGCAPKUGCICS; [M+H]+; N-[(3-Methyl-1,2,4-oxadiazol-5-YL)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -176.094; VUQAASCCQZTWOG; [M+H]+; 5-Butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.875; WONCYNYJYMAVNA; [M+H]+; 5-Tert-butyl-1,3,4-oxadiazol-3-ium-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.150; YDDAGKSURVEMCI; [M+H]+; (E)-2-(diethylamino)-2-hydroxyethenediazonium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.491; KGTZRGLLNSCJNH; [M+H]+; 5-(2-Methylpropyl)-1,3,4-oxadiazol-3-ium-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -205.175; UEUMMYRZUZKMRI; [M+H]+; 4,5-Diethyl-2,4-dihydro-3H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.370; QIXFXNMDRJRTIJ; [M+H]+; 1-(2-Hydroxyethyl)-2-methyl-5-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.615; KENWBTPXOITUBG; [M+H]+; 3-(5-Methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -219.258; LEWKFFUYRKWKLV; [M+H]+; 2-Isopropyl-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -222.486; OZVXTNDTEWDMGH; [M+H]+; 2-amino-2-(1-methyl-1H-pyrazol-4-yl)ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.052; REYGCAPKUGCICS; [M+H]+; N-[(3-Methyl-1,2,4-oxadiazol-5-YL)methyl]ethanamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H12N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 10.408
MS$FOCUSED_ION: PRECURSOR_M/Z 142.097586
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00dl-8900000000-954e8033061e2519cc8f
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0603868 861.0375 71.061000 0.2533 35.16 0.9274 92 f{C3H7N2}/0.17ppm,p-C3H5N1O1
  72.0444035 469.9902 72.045010 0.2915 27.07 0.8414 92 f{C3H6N1O1}/0.18ppm,p-C3H6N2
  84.0681183 26.3158 84.068610 1.2847 6.39 0.3071 91 f{C4H8N2}/-0.97ppm,p-C2H4N1O1
  97.0760450 59.2656 97.076390 1.1949 12.31 0.5446 92 f{C5H9N2}/0.21ppm,p-C1H3N1O1
  99.0551906 16.7350 99.055520 1.8676 4.07 0.2910 74 f{C4H7N2O1}/-1.00ppm,p-C2H5N1
  99.0916409 17.2253 99.091970 2.0082 9.65 0.3172 74 f{C5H11N2}/-0.34ppm,p-C1H1N1O1
  114.1025082 16.9348 114.102690 2.6555 4.27 0.4292 69 f{C5H12N3}/-0.57ppm,p-C1O1
  124.0869749 389.5313 124.087030 0.3546 31.28 0.7240 92 f{C6H10N3}/0.41ppm,p-H2O1
  125.0709886 101.8082 125.071030 0.8395 25.23 0.4117 92 f{C6H9N2O1}/0.39ppm,p-H3N1
  125.1072091 18.6118 125.107250 1.9903 5.79 0.3758 78 ?
  142.0974971 999.0000 142.097400 0.2604 0.00 1.0000 92 f{C6H12N3O1}/0.06ppm,p
  142.1333271 59.7681 142.133230 3.5038 13.73 0.5490 88 ?
PK$NUM_PEAK: 12
PK$PEAK: m/z int. rel.int.
  71.060387 861.04 861
  72.044403 469.99 469
  84.068118 26.32 26
  97.076045 59.27 59
  99.055191 16.73 16
  99.091641 17.23 17
  114.102508 16.93 16
  124.086975 389.53 389
  125.070989 101.81 101
  125.107209 18.61 18
  142.097497 999.00 999
  142.133327 59.77 59
//
